PCCTC Investigators Drs. Rathkopf and McBride Receive Prestigious SU2C Grant

October 17, 2019 | Press Releases

Award will fund novel trial using immunotherapy combined with radiation and hormone therapy for the treatment of metastatic prostate cancer.  

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.